Futuristic Solutions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:23 pm

Quick Insight

Futuristic Solutions Ltd, with a share price of ₹51.6 and a MarketCap of ₹54.0 Cr., presents a mixed financial picture. The company's negative Net Profit of -0.06 and an ICR of -5.48x raise concerns about its operational efficiency and debt management. However, the P/BV ratio of 4.09x indicates a potentially overvalued stock in relation to its book value. With ROE at 0.39% and ROCE at 0.26%, investors may question the company's ability to generate returns efficiently. The lack of information on key stakeholders like Promoters, FIIs, DIIs, and Public, further adds to the uncertainty. Investors should proceed with caution and conduct thorough due diligence before considering an investment in Futuristic Solutions Ltd.

Competitors of Futuristic Solutions Ltd

All Competitor Stocks of Futuristic Solutions Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:00 am

Below is a detailed analysis of the quarterly data for Futuristic Solutions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Expenses, as of Mar 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Dec 2024) to 0.15 Cr., marking an increase of 0.02 Cr..
• For Operating Profit, as of Mar 2025, the value is -0.15 Cr.. The value appears to be declining and may need further review. It has decreased from -0.13 Cr. (Dec 2024) to -0.15 Cr., marking a decrease of 0.02 Cr..
• For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
• For Other Income, as of Mar 2025, the value is 0.12 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.12 Cr..
• For Interest, as of Mar 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Dec 2024) to 0.01 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.04 Cr.. The value appears to be declining and may need further review. It has decreased from -0.01 Cr. (Dec 2024) to -0.04 Cr., marking a decrease of 0.03 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 25.00%, marking an increase of 25.00%.
• For Net Profit, as of Mar 2025, the value is -0.05 Cr.. The value appears to be declining and may need further review. It has decreased from -0.01 Cr. (Dec 2024) to -0.05 Cr., marking a decrease of 0.04 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.05. The value appears to be declining and may need further review. It has decreased from -0.01 (Dec 2024) to -0.05, marking a decrease of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:23 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:16 pm

Below is a detailed analysis of the balance sheet data for Futuristic Solutions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.47 Cr..
• For Reserves, as of Mar 2025, the value is 4.79 Cr.. The value appears to be declining and may need further review. It has decreased from 4.85 Cr. (Mar 2024) to 4.79 Cr., marking a decrease of 0.06 Cr..
• For Borrowings, as of Mar 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 0.49 Cr., marking an increase of 0.49 Cr..
• For Other Liabilities, as of Mar 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing). It has decreased from 1.66 Cr. (Mar 2024) to 0.14 Cr., marking a decrease of 1.52 Cr..
• For Total Liabilities, as of Mar 2025, the value is 15.89 Cr.. The value appears to be improving (decreasing). It has decreased from 16.98 Cr. (Mar 2024) to 15.89 Cr., marking a decrease of 1.09 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Mar 2024) to 0.02 Cr., marking a decrease of 0.01 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 1.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.99 Cr. (Mar 2024) to 1.05 Cr., marking an increase of 0.06 Cr..
• For Other Assets, as of Mar 2025, the value is 14.82 Cr.. The value appears to be declining and may need further review. It has decreased from 15.96 Cr. (Mar 2024) to 14.82 Cr., marking a decrease of 1.14 Cr..
• For Total Assets, as of Mar 2025, the value is 15.89 Cr.. The value appears to be declining and may need further review. It has decreased from 16.98 Cr. (Mar 2024) to 15.89 Cr., marking a decrease of 1.09 Cr..

Notably, the Reserves (4.79 Cr.) exceed the Borrowings (0.49 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Key Financial Ratios

After reviewing the key financial ratios for Futuristic Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has decreased from 1.35 (Mar 24) to -0.06, marking a decrease of 1.41.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has decreased from 1.35 (Mar 24) to -0.06, marking a decrease of 1.41.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 3. It has decreased from 1.36 (Mar 24) to -0.05, marking a decrease of 1.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.57. It has decreased from 14.63 (Mar 24) to 14.57, marking a decrease of 0.06.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.57. It has decreased from 14.63 (Mar 24) to 14.57, marking a decrease of 0.06.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 1.00 (Mar 24) to 0.00, marking a decrease of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.18. It has decreased from 2.90 (Mar 24) to 0.18, marking a decrease of 2.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 2. It has decreased from 1.92 (Mar 24) to -0.04, marking a decrease of 1.96.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.04. This value is below the healthy minimum of 0. It has decreased from 1.91 (Mar 24) to -0.04, marking a decrease of 1.95.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 0. It has decreased from 1.88 (Mar 24) to -0.05, marking a decrease of 1.93.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has decreased from 1.35 (Mar 24) to -0.05, marking a decrease of 1.40.
• For PBDIT Margin (%), as of Mar 25, the value is -21.80. This value is below the healthy minimum of 10. It has decreased from 66.08 (Mar 24) to -21.80, marking a decrease of 87.88.
• For PBIT Margin (%), as of Mar 25, the value is -24.06. This value is below the healthy minimum of 10. It has decreased from 65.83 (Mar 24) to -24.06, marking a decrease of 89.89.
• For PBT Margin (%), as of Mar 25, the value is -28.04. This value is below the healthy minimum of 10. It has decreased from 64.88 (Mar 24) to -28.04, marking a decrease of 92.92.
• For Net Profit Margin (%), as of Mar 25, the value is -30.66. This value is below the healthy minimum of 5. It has decreased from 46.48 (Mar 24) to -30.66, marking a decrease of 77.14.
• For Return on Networth / Equity (%), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 15. It has decreased from 9.21 (Mar 24) to -0.39, marking a decrease of 9.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is -0.31. This value is below the healthy minimum of 10. It has decreased from 11.81 (Mar 24) to -0.31, marking a decrease of 12.12.
• For Return On Assets (%), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 5. It has decreased from 8.32 (Mar 24) to -0.38, marking a decrease of 8.70.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.18 (Mar 24) to 0.01, marking a decrease of 0.17.
• For Current Ratio (X), as of Mar 25, the value is 20.81. This value exceeds the healthy maximum of 3. It has decreased from 330.14 (Mar 24) to 20.81, marking a decrease of 309.33.
• For Quick Ratio (X), as of Mar 25, the value is 13.06. This value exceeds the healthy maximum of 2. It has decreased from 218.77 (Mar 24) to 13.06, marking a decrease of 205.71.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 74.12 (Mar 24) to 0.00, marking a decrease of 74.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 73.74 (Mar 24) to 0.00, marking a decrease of 73.74.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 25.88 (Mar 24) to 0.00, marking a decrease of 25.88.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 26.26 (Mar 24) to 0.00, marking a decrease of 26.26.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -5.48. This value is below the healthy minimum of 3. It has decreased from 69.50 (Mar 24) to -5.48, marking a decrease of 74.98.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -6.71. This value is below the healthy minimum of 3. It has decreased from 49.89 (Mar 24) to -6.71, marking a decrease of 56.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 56.15. It has decreased from 117.44 (Mar 24) to 56.15, marking a decrease of 61.29.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 282.74. This value exceeds the healthy maximum of 3. It has increased from 38.64 (Mar 24) to 282.74, marking an increase of 244.10.
• For EV / EBITDA (X), as of Mar 25, the value is -1,296.83. This value is below the healthy minimum of 5. It has decreased from 58.47 (Mar 24) to -1,296.83, marking a decrease of 1,355.30.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 314.25. This value exceeds the healthy maximum of 3. It has increased from 40.83 (Mar 24) to 314.25, marking an increase of 273.42.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 25.87 (Mar 24) to 0.00, marking a decrease of 25.87.
• For Price / BV (X), as of Mar 25, the value is 4.09. This value exceeds the healthy maximum of 3. It has decreased from 8.10 (Mar 24) to 4.09, marking a decrease of 4.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 315.29. This value exceeds the healthy maximum of 3. It has increased from 40.83 (Mar 24) to 315.29, marking an increase of 274.46.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness